135 related articles for article (PubMed ID: 27689533)
1. Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo.
Anderson RC; Makvandi M; Xu K; Lieberman BP; Zeng C; Pryma DA; Mach RH
Nucl Med Biol; 2016 Dec; 43(12):752-758. PubMed ID: 27689533
[TBL] [Abstract][Full Text] [Related]
2. High affinity and low PARP-trapping benzimidazole derivatives as a potential warhead for PARP1 degraders.
Peng X; Li Y; Qu J; Jiang L; Wu K; Liu D; Chen Y; Peng J; Guo Y; Cao X
Eur J Med Chem; 2024 May; 271():116405. PubMed ID: 38678823
[TBL] [Abstract][Full Text] [Related]
3. PARP-1-Targeted Radiotherapy in Mouse Models of Glioblastoma.
Jannetti SA; Carlucci G; Carney B; Kossatz S; Shenker L; Carter LM; Salinas B; Brand C; Sadique A; Donabedian PL; Cunanan KM; Gönen M; Ponomarev V; Zeglis BM; Souweidane MM; Lewis JS; Weber WA; Humm JL; Reiner T
J Nucl Med; 2018 Aug; 59(8):1225-1233. PubMed ID: 29572254
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888.
Karlberg T; Hammarström M; Schütz P; Svensson L; Schüler H
Biochemistry; 2010 Feb; 49(6):1056-8. PubMed ID: 20092359
[TBL] [Abstract][Full Text] [Related]
5. PARP-1 Expression Quantified by [
Sander Effron S; Makvandi M; Lin L; Xu K; Li S; Lee H; Hou C; Pryma DA; Koch C; Mach RH
Cancer Biother Radiopharm; 2017 Feb; 32(1):9-15. PubMed ID: 28118040
[TBL] [Abstract][Full Text] [Related]
6. A functional ex vivo assay to detect PARP1-EJ repair and radiosensitization by PARP-inhibitor in prostate cancer.
Köcher S; Beyer B; Lange T; Nordquist L; Volquardsen J; Burdak-Rothkamm S; Schlomm T; Petersen C; Rothkamm K; Mansour WY
Int J Cancer; 2019 Apr; 144(7):1685-1696. PubMed ID: 30478958
[TBL] [Abstract][Full Text] [Related]
7. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo.
Zmuda F; Malviya G; Blair A; Boyd M; Chalmers AJ; Sutherland A; Pimlott SL
J Med Chem; 2015 Nov; 58(21):8683-93. PubMed ID: 26469301
[TBL] [Abstract][Full Text] [Related]
9. An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors.
Liu X; Palma J; Kinders R; Shi Y; Donawho C; Ellis PA; Rodriguez LE; Colon-Lopez M; Saltarelli M; LeBlond D; Lin CT; Frost DJ; Luo Y; Giranda VL
Anal Biochem; 2008 Oct; 381(2):240-7. PubMed ID: 18674509
[TBL] [Abstract][Full Text] [Related]
10. A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy.
Makvandi M; Xu K; Lieberman BP; Anderson RC; Effron SS; Winters HD; Zeng C; McDonald ES; Pryma DA; Greenberg RA; Mach RH
Cancer Res; 2016 Aug; 76(15):4516-24. PubMed ID: 27261505
[TBL] [Abstract][Full Text] [Related]
11. PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.
Mariano G; Ricciardi MR; Trisciuoglio D; Zampieri M; Ciccarone F; Guastafierro T; Calabrese R; Valentini E; Tafuri A; Del Bufalo D; Caiafa P; Reale A
Oncotarget; 2015 Jun; 6(17):15008-21. PubMed ID: 25938539
[TBL] [Abstract][Full Text] [Related]
12. Radioiodinated PARP1 tracers for glioblastoma imaging.
Salinas B; Irwin CP; Kossatz S; Bolaender A; Chiosis G; Pillarsetty N; Weber WA; Reiner T
EJNMMI Res; 2015 Dec; 5(1):123. PubMed ID: 26337803
[TBL] [Abstract][Full Text] [Related]
13. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
Hopkins TA; Shi Y; Rodriguez LE; Solomon LR; Donawho CK; DiGiammarino EL; Panchal SC; Wilsbacher JL; Gao W; Olson AM; Stolarik DF; Osterling DJ; Johnson EF; Maag D
Mol Cancer Res; 2015 Nov; 13(11):1465-77. PubMed ID: 26217019
[TBL] [Abstract][Full Text] [Related]
15. A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy.
Destro G; Chen Z; Chan CY; Fraser C; Dias G; Mosley M; Guibbal F; Gouverneur V; Cornelissen B
Nucl Med Biol; 2023; 116-117():108312. PubMed ID: 36621256
[TBL] [Abstract][Full Text] [Related]
16. Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.
Liu X; Shi Y; Maag DX; Palma JP; Patterson MJ; Ellis PA; Surber BW; Ready DB; Soni NB; Ladror US; Xu AJ; Iyer R; Harlan JE; Solomon LR; Donawho CK; Penning TD; Johnson EF; Shoemaker AR
Clin Cancer Res; 2012 Jan; 18(2):510-23. PubMed ID: 22128301
[TBL] [Abstract][Full Text] [Related]
17. Solid phase radiosynthesis of an olaparib derivative using 4-[
Xu J; Chen H; Rogers BE; Katzenellenbogen JA; Zhou D
Nucl Med Biol; 2022; 114-115():65-70. PubMed ID: 36193598
[TBL] [Abstract][Full Text] [Related]
18. PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
Stanley J; Klepczyk L; Keene K; Wei S; Li Y; Forero A; Grizzle W; Wielgos M; Brazelton J; LoBuglio AF; Yang ES
Breast Cancer Res Treat; 2015 Apr; 150(3):569-79. PubMed ID: 25833211
[TBL] [Abstract][Full Text] [Related]
19. Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies.
Ding X; Ray Chaudhuri A; Callen E; Pang Y; Biswas K; Klarmann KD; Martin BK; Burkett S; Cleveland L; Stauffer S; Sullivan T; Dewan A; Marks H; Tubbs AT; Wong N; Buehler E; Akagi K; Martin SE; Keller JR; Nussenzweig A; Sharan SK
Nat Commun; 2016 Aug; 7():12425. PubMed ID: 27498558
[TBL] [Abstract][Full Text] [Related]
20. DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy.
Nguyen NT; Pacelli A; Nader M; Kossatz S
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
